JDRF Blog
Top Type 1 Diabetes Advances of Fiscal Year 2023
JDRF highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
Read More About Top Type 1 Diabetes Advances of Fiscal Year 2023
At ADA 2023, JDRF-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
JDRF joined thousands at the ADA's Scientific Sessions, where experts presented significant advancements in diabetes research and clinical trials.
Read More About At ADA 2023, JDRF-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
FDA Clears a New Artificial Pancreas System
The FDA cleared the iLet Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1 diabetes.
Read More About FDA Clears a New Artificial Pancreas System
Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and Teens
The CLVer study found that newly diagnosed individuals on verapamil were making more insulin one year after diagnosis than those on placebo.
Read More About Verapamil Slows Type 1 Diabetes Progression in Newly Diagnosed Children and TeensRecent Articles
Sign up for our monthly Research Newsletter, The Pipeline, to stay up to date on the latest and greatest in T1D science.
By clicking Sign Up, I agree to the JDRF Privacy Policy. I also agree to receive emails from JDRF and I understand that I may opt out of JDRF subscriptions at any time.